Application
Figure 1:Black line: Control Antigen (100 ng);Purple line: Antigen (10ng); Blue line: Antigen (50 ng); Red line:Antigen (100 ng)Application
Figure 2:Western blot analysis using C3C mAb against human C3C (AA: 1521-1649) recombinant protein. (Expected MW is 40.7 kDa)Application
Figure 3:Western blot analysis using C3C mAb against HEK293 (1) and C3C (AA: 1521-1649)-hIgGFc transfected HEK293 (2) cell lysate.Application
Figure 4:Immunohistochemical analysis of paraffin-embedded ovarian cancer tissues using C3C mouse mAb with DAB staining.Application
Figure 5:Immunohistochemical analysis of paraffin-embedded endometrial cancer tissues using C3C mouse mAb with DAB staining.| Product Name | C3C |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | ASP; C3a; C3b; AHUS5; ARMD9; CPAMD1; HEL-S-62p |
| Immunogen | Purified recombinant fragment of human C3C (AA: 1521-1649) expressed in E. Coli. |
| Clonality | Monoclonal |
|---|---|
| Host Species | Unknow |
| Tested Applications | WBIHCICC/IF |
| WB:1:250~1:1000 IHC:1:20~1:100 ICC/IF:1:100~1:200 Notes:Optimal dilutions/concentrations should be determined by the researcher. |
|
| Species Reactivity | Human |
| Alternative Names | ASP C3a C3b AHUS5 ARMD9 CPAMD1 HEL-S-62p |
|---|---|
| Molecular Weight(MW) | 187.1kDa |
| Entrez Gene | 718 |
|---|
Application
Figure 1:Black line: Control Antigen (100 ng);Purple line: Antigen (10ng); Blue line: Antigen (50 ng); Red line:Antigen (100 ng)
Application
Figure 2:Western blot analysis using C3C mAb against human C3C (AA: 1521-1649) recombinant protein. (Expected MW is 40.7 kDa)
Application
Figure 3:Western blot analysis using C3C mAb against HEK293 (1) and C3C (AA: 1521-1649)-hIgGFc transfected HEK293 (2) cell lysate.
Application
Figure 4:Immunohistochemical analysis of paraffin-embedded ovarian cancer tissues using C3C mouse mAb with DAB staining.
Application
Figure 5:Immunohistochemical analysis of paraffin-embedded endometrial cancer tissues using C3C mouse mAb with DAB staining.| Application Notes | WB:1:250~1:1000 IHC:1:20~1:100 ICC/IF:1:100~1:200 Notes:Optimal dilutions/concentrations should be determined by the researcher. |
|---|
| Form | Purified antibody in PBS with 0.05% sodium azide |
|---|---|
| Storage Instructions | 4℃; -20℃ for long term storage |
